| Literature DB >> 32342016 |
Sadaf Malik1, Tarjei Tørre Asprusten1,2, Maria Pedersen3, Julie Mangersnes1, Gro Trondalen4, Betty van Roy1, Eva Skovlund5, Vegard Bruun Wyller1,2.
Abstract
Entities:
Keywords: Epstein-Barr virus infection; adolescents; chronic fatigue; chronic fatigue syndrome; cognitive–behavioural therapy; music therapy
Year: 2020 PMID: 32342016 PMCID: PMC7173952 DOI: 10.1136/bmjpo-2019-000620
Source DB: PubMed Journal: BMJ Paediatr Open ISSN: 2399-9772
Figure 1Flow chart of study participants. CFQ, Chalder Fatigue Questionnaire; EBV, Epstein-Barr virus; RCT, randomised controlled trial.
Figure 2Graphical depiction of the 10 therapy sessions in the mental training programme. CBT, cognitive–behavioural therapy.
Background characteristics
| Included (n=43) | Eligible, not included (n=48) | ||
| Treatment (n=21) | Control (n=22) | ||
| Sex, n (%) | |||
| Male | 4 (19) | 6 (27) | 14 (29) |
| Female | 17 (81) | 16 (73) | 34 (71) |
| Age (years), mean (SD) | 17.7 (1.4) | 16.9 (1.7) | 17.4 (1.4) |
| BMI (kg/m2), mean (SD) | 22.5 (3.3) | 21.6 (2.3) | 22.1 (2.7) |
| Adheres to Canada 2003 criteria, n (%) | |||
| Yes | 3 (14) | 7 (32) | 9 (19) |
| No | 18 (86) | 15 (68) | 39 (81) |
| Adheres to Fukuda criteria, n (%) | |||
| Yes | 5 (24) | 11 (50) | 10 (21) |
| No | 16 (76) | 11 (50) | 38 (79) |
| Epstein-Barr virus (EBV) load, copies in blood, n (%) | |||
| Negative (<160) | 9 (43) | 13 (65) | 22 (49) |
| Low (1600–2000) | 7 (33) | 5 (25) | 14 (31) |
| Moderate/high (>2000) | (5 (24) | 2 (10) | 9 (20) |
| EBV-VCA-IgG, titre, median (IQR) | 152 (107) | 181 (212) | 175.5 (198) |
| Blood cytotoxic T cell (CD8+) count (109 cells/L), mean (SD) | 0.68 (0.25) | 0.65 (0.23) | 0.63 (0.25) |
| Efficacy variables | |||
| Chalder Fatigue Questionnaire (CFQ), total sum score, mean (SD) | 20.0 (3.3) | 19.4 (2.9) | 19.1 (4.8) |
| Postexertional malaise, score, mean (SD) | 2.9 (1.5) | 2.8 (1.3) | 2.7 (1.2) |
| Brief Pain Inventory (BPI), total sum score, mean (SD) | 10.4 (5.2) | 13.1 (4.5) | 11.5 (5.5) |
| Karolinska Sleep Questionnaire (KSQ), total sum score, mean (SD) | 53.0 (14.9) | 45.6 (10.7) | 52.0 (13.4) |
| Hospital Anxiety and Depression Scale (HADS), total sum score, mean (SD) | 13.1 (5.8) | 16.5 (6.5) | 12.1 (6.2) |
| Pediatric Quality of Life Inventory (PedsQL), total average score, mean (SD) | 67 (14) | 62 (15) | 70 (18) |
| Functional Disability Inventory, total sum score, mean (SD) | 12.2 (8.8) | 13.7 (8.3) | 10.1 (10.9) |
| Steps/day (n), mean (SD) | 7998 (4598) | 8376 (3119) | 9255 (3795) |
P values are based on χ2 test, Fisher's exact test, Student’s t-test or Mann-Whitney test, as appropriate.
BMI, body mass index; VCA, viral capsid antigen.
Protocol deviations
| Treatment | Control | Treatment | Control | |||||
| 3 months after baseline | 15 months after baseline | |||||||
| Lost to follow-up |
|
|
|
|
|
|
|
|
| No | 15 | 71 | 21 | 95 | 13 | 87 | 19 | 90 |
| Yes | 6 | 29 | 1 | 5 | 2 | 13 | 2 | 10 |
| Interruption of therapy | ||||||||
| No | 15 | 71 | n.a | n.a. | n.a. | n.a. | n.a. | n.a. |
| Yes* | 6 | 29 | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. |
| Diagnosed with another chronic disorder | ||||||||
| No | 15 | 100 | 21 | 100 | 13 | 100 | 19 | 100 |
| Yes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Experienced severe illness/trauma | ||||||||
| No | 15 | 100 | 21 | 100 | 13 | 100 | 19 | 100 |
| Yes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receiving other therapy for chronic fatigue | ||||||||
| No | 15 | 100 | 21 | 100 | 12 | 92 | 19 | 100 |
| Yes | 0 | 0 | 0 | 0 | 1 | 8 | 0 | 0 |
*The six individuals who interrupted therapy were the same individuals who were lost to follow-up in the intervention group.
n.a., not applicable.
Outcome of the mental training programme intervention
| 3 months after baseline | 15 months after baseline | |||
| Intention to treat | Per protocol | Intention to treat | Per protocol | |
| CFQ—total sum score | ||||
| Treatment group, mean | 19.5 | 19.0 | 16.8 | 14.3 |
| Control group, mean | 20.7 | 20.3 | 18.3 | 18.1 |
| Difference (95% CI) | −1.1 (−4.1 to 1.9) | −1.4 (−5.3 to 2.6) | −1.5 (−6.1 to 3.1) | −3.8 (−9.6 to 2.1) |
| Postexertional malaise—score | ||||
| Treatment group, mean | 2.7 | 2.4 | 2.3 | 1.7 |
| Control group, mean | 3.1 | 2.9 | 2.5 | 2.1 |
| Difference (95% CI) | −0.4 (−0.9 to 0.1) | −0.5 (−1.1 to 0.01) | −0.2 (−0.8 to 0.5) | −0.4 (−1.0 to 0.3) |
| BPI—total sum score | ||||
| Treatment group, mean | 11.3 | 10.7 | 12.5 | 12.9 |
| Control group, mean | 11.7 | 12.4 | 10.6 | 11.0 |
| Difference (95% CI) | −0.4 (−2.9 to 2.2) | −1.7 (−5.1 to 1.6) | 1.8 (−1.0 to 4.7) | 1.9 (−2.5 to 6.3) |
| KSQ—total sum score | ||||
| Treatment group, mean | 47.0 | 44.2 | 45.3 | 41.1 |
| Control group, mean | 46.2 | 47.9 | 43.3 | 44.6 |
| Difference (95% CI) | 0.8 (−8.1 to 9.7) | −3.8 (−10.9 to 3.4) | 2.0 (−7.4 to 11.3) | −3.5 (−14.4 to 7.4) |
| HADS—total sum score | ||||
| Treatment group, mean | 15.1 | 13.9 | 12.8 | 10.0 |
| Control group, mean | 15.1 | 14.2 | 13.5 | 12.4 |
| Difference (95% CI) | −0.1 (−2.7 to 2.5) | −0.3 (−3.8 to 3.2) | −0.7 (−3.8 to 2.5) | −2.4 (−6.0 to 1.3) |
| PedsQL—total average score | ||||
| Treatment group, mean | 65.9 | 69.8 | 69.0 | 75.9 |
| Control group, mean | 64.0 | 66.6 | 71.7 | 74.4 |
| Difference (95% CI) | 1.8 (−4.1 to 7.7) | 3.2 (−4.1 to 10.5) | −2.7 (−11.6 to 6.2) | 1.4 (−9.2 to 12.0) |
| FDI—total sum score | ||||
| Treatment group, mean | 12.4 | 11.0 | 10.6 | 7.4 |
| Control group, mean | 12.9 | 12.8 | 10.4 | 10.7 |
| Difference (95% CI) | −0.4 (−3.5 to 2.6) | −1.8 (−5.5 to 1.9) | 0.2 (−4.3 to 4.6) | −3.3 (−9.0 to 2.4) |
| Steps per day, n | ||||
| Treatment group, mean | 7138 | 6198 | 7165 | 7540 |
| Control group, mean | 8296 | 8257 | 8039 | 7782 |
| Difference (95% CI) | −1158 (−2642 to 325) | −2059 (−3698 to −421) | −874 (−2800 to 1052) | −242 (−2944 to 2460) |
All analyses in the intention to treat columns are based on imputation of missing values based on the ‘last observation carried forward’ principle. Means and differences 3 and 15 months after baseline are estimated from the parameters of the general linear model. Model diagnostics were performed by visual inspection of residual plots.
BPI, Brief Pain Inventory; CFQ, Chalder Fatigue Questionnaire; FDI, Functional Disability Inventory; HADS, Hospital Anxiety and Depression Scale; KSQ, Karolinska Sleep Questionnaire; PedsQL, Pediatric Quality of Life Inventory.
Figure 3Development of steps/day, fatigue and postexertional malaise over time in the intervention group (red) and the control group (blue), based on imputed data sets. The grey area represents the time period in which the mental training programme was provided. EBV, Epstein-Barr virus.
Number of recovered patients 3 and 15 months after baseline
| 3 months after baseline | 15 months after baseline | |||||||
| Recovered | Not recovered | Recovered | Not recovered | |||||
| n | % | n | % | n | % | n | % | |
| Treatment group | 3 | 21 | 11 | 79 | 8 | 62 | 5 | 38 |
| Control group | 4 | 20 | 16 | 80 | 7 | 37 | 12 | 63 |
| Total | 7 | 21 | 27 | 79 | 15 | 47 | 17 | 53 |
Recovery was defined as a total sum score ≤3 on the Chalder Fatigue Questionnaire (each item scored 0-0-1-1), analogous to the case definition of chronic fatigue used as inclusion criterion in the present study. P values are based on Fisher's exact test or χ2 test, as appropriate.
Adverse effects, self-reported
| 3 months after baseline | 15 months after baseline | |||||||
| Treatment | Control | Treatment | Control | |||||
| n | % | n | % | n | % | n | % | |
| Total | ||||||||
| No | 9 | 60 | 12 | 57 | 9 | 69 | 14 | 74 |
| Yes | 6 | 40 | 9 | 43 | 4 | 31 | 5 | 26 |
| More fatigued | ||||||||
| No | 13 | 87 | 18 | 86 | 13 | 100 | 18 | 95 |
| Yes | 2 | 13 | 3 | 14 | 0 | 0 | 1 | 5 |
| More attention problems | ||||||||
| No | 13 | 87 | 15 | 71 | 12 | 92 | 17 | 89 |
| Yes | 2 | 13 | 6 | 29 | 1 | 8 | 2 | 11 |
| More pain | ||||||||
| No | 15 | 100 | 18 | 86 | 13 | 100 | 18 | 95 |
| Yes | 0 | 0 | 3 | 14 | 0 | 0 | 1 | 5 |
| More sad/depressed | ||||||||
| No | 11 | 73 | 20 | 95 | 10 | 77 | 19 | 100 |
| Yes | 4 | 27 | 1 | 5 | 3 | 23 | 0 | 0 |
| Less schoolwork | ||||||||
| No | 14 | 93 | 17 | 85 | 11 | 92 | 16 | 89 |
| Yes | 1 | 7 | 3 | 15 | 1 | 8 | 2 | 11 |
| Any incident of self-harm | ||||||||
| No | 14 | 93 | 21 | 100 | 13 | 100 | 19 | 100 |
| Yes | 1 | 7 | 0 | 0 | 0 | 0 | 0 | 0 |
| Any thoughts/fantasies about suicide | ||||||||
| No | 15 | 100 | 20 | 100 | 13 | 100 | 18 | 95 |
| Yes | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 5 |